Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration

Clinical trial NCT00767949 · UNKNOWN

Trial details

NCT number: NCT00767949
Sponsor: Lpath, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Neovascular Age Related Macular Degeneration

Start date: 2008-10-01
Primary completion: 2010-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.